We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Clinical Tool Identifies Patients Who Do Not Require Cardiac Monitoring

By HospiMedica International staff writers
Posted on 08 Feb 2017
Emergency departments (EDs) have a new clinical decision tool to identify patients with chest pain who can be removed safely from cardiac monitoring, according to a new study.

Researchers at Ottawa Hospital and the University of Ottawa conducted a prospective study involving 796 patients (mean age 63.8 years, 55.8% male) who presented to the ED with chest pain, in order to validate the Ottawa Chest Pain Cardiac Monitoring Rule, a decision tool for safe removal of patients from cardiac monitoring after an initial evaluation in the ED. More...
The researchers collected baseline characteristics, clinical evaluations, and patient predictors, such as electrocardiogram (ECG) readings.

The researchers then calculated diagnostic characteristics for the clinical prediction rule. The outcome was a tool that helps identify arrhythmia requiring intervention while in the ED, or within eight hours of presentation. Study results showed that of all the patients monitored, only 1.9% suffered an arrhythmia during their stay in the ED. Following the new rule would have enabled 284 (35.7%) of these patients to be safely removed from cardiac monitoring. The study was published on January 30, 2016, in the Canadian Medical Association Journal (CMAJ).

“Overall, the management of chest pain patients has not changed much in the past 10 years, with most patients requiring serial blood tests to rule out heart attack and end up staying in the emergency department for few hours,” said senior author Venkatesh Thiruganasambandamoorthy, MD, PhD. “A substantial number of patients are unnecessarily being placed on cardiac monitoring, while this resource is needed for patients in the waiting room who are more ill.”

“We recommend that patients who present to the emergency department with chest pain be removed from cardiac monitoring if they are free of chest pain at the time of assessment, and if the ECG is either normal or shows only nonspecific changes,” concluded Dr. Thiruganasambandamoorthy and colleagues. “The results, if implemented, should have a significant and positive impact on wait times and increase the availability of monitored beds for sicker patients.”


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Emergency Ventilator
Shangrila935
Mobile X-Ray System
K4W
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.